India Insulin Delivery Devices Market Size & Outlook
Related Markets
India insulin delivery devices market highlights
- The India insulin delivery devices market generated a revenue of USD 565.2 million in 2025 and is expected to reach USD 928.3 million by 2033.
- The India market is expected to grow at a CAGR of 6.1% from 2026 to 2033.
- In terms of segment, insulin pens was the largest revenue generating product in 2025.
- Insulin Pumps is the most lucrative product segment registering the fastest growth during the forecast period.
Insulin delivery devices market data book summary
| Market revenue in 2025 | USD 565.2 million |
| Market revenue in 2033 | USD 928.3 million |
| Growth rate | 6.1% (CAGR from 2026 to 2033) |
| Largest segment | Insulin pens |
| Fastest growing segment | Insulin Pumps |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Insulin Pens, Insulin Pumps, Insulin Pen Needles, Insulin Syringes |
| Key market players worldwide | Novo Nordisk A/S ADR, Sanofi SA, Eli Lilly and Co, Ypsomed Holding AG, Medtronic PLC, Abbott Laboratories, Roche, Biocon, Wockhardt |
Other key industry trends
- In terms of revenue, India accounted for 2.9% of the global insulin delivery devices market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, Japan insulin delivery devices market is projected to lead the regional market in terms of revenue in 2033.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 2,265.1 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Insulin Delivery Devices Market Scope
Insulin Delivery Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Wockhardt | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | http://wockhardt.com |
| Biocon | View profile | 10001+ | Bangalore, Karnataka, India, Asia | http://www.biocon.com |
| Ypsomed Holding AG | View profile | 2400 | Brunnmattstrasse 6, Burgdorf, Switzerland, 3401 | https://www.ypsomed.com |
| Roche | View profile | 10001+ | Basel, Basel-Stadt, Switzerland, Europe | http://www.roche.com |
| Novo Nordisk A/S ADR | View profile | 66015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | https://www.novonordisk.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
India insulin delivery devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to insulin delivery devices market will help companies and investors design strategic landscapes.
Insulin pens was the largest segment with a revenue share of 48.05% in 2025. Horizon Databook has segmented the India insulin delivery devices market based on insulin pens, insulin pumps, insulin pen needles, insulin syringes covering the revenue growth of each sub-segment from 2021 to 2033.
In India, around 80.52 million people have diabetes, and by 2027, around 92 million (nearly 10%) of India’s population is expected to be diagnosed with diabetes. Factors such as physical inactivity, obesity, high-sugar, high-calorie, and high-fat diet are increasing the prevalence of diabetes in India.
In addition, IDF estimated that nearly 10% of global health expenditure is spent on diabetes in India. As per the Ministry of Health & Family Welfare of the Government of India, over 60% of deaths are due to Noncommunicable Diseases (NCDs), such as diabetes, chronic respiratory diseases, cardiovascular diseases, cancer, and others.
Moreover, to prevent and control major NCDs, the National Program for Prevention & Control of Cancer, Diabetes, Cardiovascular Diseases, and Stroke (NPCDCS) includes health awareness in schools, medical education, and urban planning for diabetes.
Reasons to subscribe to India insulin delivery devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of India insulin delivery devices market databook
-
Our clientele includes a mix of insulin delivery devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India insulin delivery devices market , including forecasts for subscribers. This country databook contains high-level insights into India insulin delivery devices market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
India Product - Insulin Delivery Devices Market size, 2025 - 2033 (US$M)
India Insulin Delivery Devices Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
